EP3972603
Aðferðir til meðhöndlunar á sjögrens-heilkennum með því að nota brútons-týrósín-kínasa-hindra
:
EP einkaleyfi í gildi á Íslandi:
20.5.2020:
4.9.2024:
20729203.8
:
28.11.2024:
15.12.2024
:
19.5.2040:
19.5.2026:
31.5.2026
:
METHODS OF TREATING SJÖGREN'S SYNDROME USING A BRUTON'S TYROSINE KINASE INHIBITOR
20.5.2020
4.9.2024
28.11.2024
15.12.2024
19.5.2026
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
BHATTACHARYA, Souvik:
Cambridge, Massachusetts 02139, US
:
BIETH, Bruno:
4002 Basel, CH
:
CABANSKI, Maciej:
4002 Basel, CH
:
CENNI, Bruno:
4002 Basel, CH
:
DE BUCK, Stefan:
4002 Basel, CH
:
KAUL, Martin:
4002 Basel, CH
:
KINHIKAR, Arvind:
Cambridge, Massachusetts 02139, US
:
RADIVOJEVIC, Andrijana:
East Hanover, New Jersey 07936, US
:
VITALITI GARAMI, Alessandra:
4002 Basel, CH
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201962851994 P:
23.5.2019:
US
:
IB2020054754:
20.5.2020
:
A61K 31/505, A61P 37/00
: 6
: 14.5.2025
: 19.5.2026
: Árnason Faktor ehf.